Acurx raises ~$2.5M in registered direct offering plus up to $4.6M from warrants

Acurx Pharmaceuticals, Inc.

Priced 825,085 shares (or pre-funded warrants) at $3.03/share for ~$2.5M gross proceeds.
Concurrent private placement of 1,650,170 Series H warrants at $2.78/share, exercisable for 24 months.
Potential additional gross proceeds of ~$4.6M if short-term warrants fully exercised on cash basis.
Proceeds to be used for working capital and general corporate purposes.
H.C. Wainwright & Co. acted as exclusive placement agent; fees 6.0% of gross proceeds.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Acurx Pharmaceuticals, Inc. entered into Securities Purchase Agreement with the investors named therein (the "Investors") valued at aggregate gross proceeds of approximately $2.5 million (effective 2026-04-15).

Action: entry
Agreement: equity purchase
Counterparty: the investors named therein (the "Investors")
Value: aggregate gross proceeds of approximately $2.5 million
Effective: 2026-04-15

Exact text from the filing

On April 15, 2026, Acurx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the investors named therein (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the “Registered Offering”) (i) 816,068 shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a purchase price of $3.03 per share and (ii) pre-funded common stock purchase warrants (the “Pre-Funded Warrants”) to purchase up to 9,017 shares of Common Stock (the “Pre-Funded Warrant Shares”) at a purchase price of $3.029 per share for aggregate gross proceeds of approximately $2.5 million

View on SEC.gov

Browse all material agreements →

Acurx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-044093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.